Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 9/20 | 0.80 |
| ▸ | CA9 | Q16790 | 9/20 | 0.80 |
| ▸ | CA1 | P00915 | 8/20 | 0.80 |
| ▸ | CA7 | P43166 | 7/20 | 0.80 |
| ▸ | CA14 | Q9ULX7 | 7/20 | 0.80 |
| ▸ | CA6 | P23280 | 6/20 | 0.80 |
| ▸ | CA4 | P22748 | 6/20 | 0.80 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.80 |
| ▸ | CA2 | P00918 | 5/20 | 0.80 |
| ▸ | CA5A | P35218 | 5/20 | 0.80 |
| ▸ | CA3 | P07451 | 5/20 | 0.80 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.80 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.80 |
| ▸ | LMNA | P02545 | 2/20 | 0.80 |
| ▸ | SOST | Q9BQB4 | 1/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | GLA | P06280 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Coumarin SCHEMBL21084335 | 0.90 | CA12 (0.77) | CA12CA9CA1CA7CA14 | |
| Coumarin SCHEMBL8214245 | 0.90 | CA12 (0.77) | CA12CA9CA1CA7CA14 | |
| Coumarin SCHEMBL29385611 | 0.89 | CA12 (1.00) | CA12CA9CA1CA7CA14 | |
| Coumarin SCHEMBL28886137 | 0.89 | CA12 (1.00) | CA12CA9CA1CA7CA14 | |
| Coumarin SCHEMBL6252 | 0.89 | CA12 (1.00) | CA12CA9CA1CA7CA14 | |
| Coumarin SCHEMBL3441294 | 0.89 | CA12 (1.00) | CA12CA9CA1CA7CA14 | |
| Coumarin SCHEMBL621751 | 0.89 | CA12 (1.00) | CA12CA9CA1CA7CA14 | |
| Coumarin SCHEMBL1038138 | 0.89 | CA12 (1.00) | CA12CA9CA1CA7CA14 | |
| Coumarin SCHEMBL11101317 | 0.88 | CA12 (0.87) | CA12CA9CA1CA7CA14 | |
| Coumarin SCHEMBL9643642 | 0.87 | CA12 (0.95) | CA12CA9CA1CA7CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4680677-A1 | BENZOTHIENOPYRROLE CYANINE DYES | Beckman Coulter, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| US-20250383357-A1 | NOVEL FLUORESCENT DYES AND POLYMERS FROM DIHYDROPHENANTHRENE DERIVATIVES | BECKMAN COULTER INC (US) | 2025-12-18 | — | — | US | disclosed |
| EP-4547759-A2 | NOVEL FLUORESCENT DYES AND POLYMERS FROM DIHYDROPHENANTHRENE DERIVATIVES | Beckman Coulter, Inc. (US) | 2025-05-07 | — | — | EP | disclosed |
| WO-2025064842-A1 | DIHYDROPHENANTHRENE (DHP) BRIDGED DYES FOR USE IN FLOW CYTOMETRY | BECKMAN COULTER, INC. (US) | 2025-03-27 | — | — | WO | disclosed |
| US-20240400893-A1 | WATER-SOLUBLE TETRAHYDROPYRENE BASED FLUORESCENT POLYMERS | BECKMAN COULTER, INC. | 2024-12-05 | — | — | US | disclosed |
| WO-2024196805-A1 | BENZOTHIENOPYRROLE CYANINE DYES | BECKMAN COULTER, INC. (US) | 2024-09-26 | — | — | WO | disclosed |
| US-20240270971-A1 | UV-ABSORBING POLYMERS, COMPOSITIONS AND USES THEREOF | BECKMAN COULTER, INC. | 2024-08-15 | — | — | US | disclosed |
| EP-4334395-A1 | UV-ABSORBING POLYMERS, COMPOSITIONS AND USES THEREOF | Beckman Coulter, Inc. (US) | 2024-03-13 | — | — | EP | disclosed |
| WO-2024044327-A1 | DHNT MONOMERS AND POLYMER DYES WITH MODIFIED PHOTOPHYSICAL PROPERTIES | BECKMAN COULTER, INC. (US) | 2024-02-29 | — | — | WO | disclosed |
| WO-2024007016-A2 | NOVEL FLUORESCENT DYES AND POLYMERS FROM DIHYDROPHENANTHRENE DERIVATIVES | BECKMAN COULTER, INC. (US) | 2024-01-04 | — | — | WO | disclosed |
| US-20100297725-A1 | Haptens, hapten conjugates, compositions thereof and method for their preparation and use | VENTANA MEDICAL SYSTEMS, INC. | 2010-11-25 | — | — | US | disclosed |
| US-20100184087-A1 | Haptens, hapten conjugates, compositions thereof and method for their preparation and use | VENTANA MEDICAL SYSTEMS, INC. | 2010-07-22 | — | — | US | disclosed |
| US-7695929-B2 | Derivatives containing oxazole, pyrazole, thiazole, nitroaryl compound, benzofurazan, triterpene, urea, thiourea, rotenoid, coumarin or cyclolignan such as 4-(2-hydroxyphenyl)-1H-benzo[b][1,4]diazepine-2(3H)-one; multiplexed diagnostic assay for multiple targets in sample; antibodies; kits | VENTANA MEDICAL SYSTEMS, INC. (US) | 2010-04-13 | — | — | US | disclosed |
| EP-2167963-A2 | POLYMERIC CARRIERS FOR IMMUNOHISTOCHEMISTRY AND IN SITU HYBRIDIZATION | Ventana Medical Systems, Inc. (US) | 2010-03-31 | — | — | EP | disclosed |
| EP-2078197-A2 | HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE | Ventana Medical Systems, Inc. (US) | 2009-07-15 | — | — | EP | disclosed |
| WO-2008153744-A2 | POLYMERIC CARRIERS FOR IMMUNOHISTOCHEMISTRY AND IN SITU HYBRIDIZATION | VENTANA MEDICAL SYSTEMS, INC. (US) | 2008-12-18 | — | — | WO | disclosed |
| US-20080305497-A1 | Polymeric carriers for immunohistochemistry and in situ hybridization | VENTANA MEDICAL SYSTEMS, INC. | 2008-12-11 | — | — | US | disclosed |
| US-20080268462-A1 | Derivatives containing oxazole, pyrazole, thiazole, nitroaryl compound, benzofurazan, triterpene, urea, thiourea, rotenoid, coumarin or cyclolignan such as 4-(2-hydroxyphenyl)-1H-benzo[b][1,4]diazepine-2(3H)-one; multiplexed diagnostic assay for multiple targets in sample; antibodies; kits | VENTANA MEDICAL SYSTEMS, INC. | 2008-10-30 | — | — | US | disclosed |
| WO-2008063378-A9 | HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE | VENTANA MED SYST INC (US) | 2008-07-31 | — | — | WO | disclosed |
| WO-2008063378-A2 | HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE | VENTANA MEDICAL SYSTEMS, INC. (US) | 2008-05-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080268462-A1 | Derivatives containing oxazole, pyrazole, thiazole, nitroaryl compound, benzofurazan, triterpene, urea, thiourea, rotenoid, coumarin or cyclolignan such as 4-(2-hydroxyphenyl)-1H-benzo[b][1,4]diazepine-2(3H)-one; multiplexed diagnostic assay for multiple targets in sample; antibodies; kits | HRH4, CRBN, NCDN | CA12 1373/4885CA9 3488/4885CA1 2248/4885 |
| US-20100297725-A1 | Haptens, hapten conjugates, compositions thereof and method for their preparation and use | CRBN, GABBR1, SHBG | CA12 1700/4885CA9 3668/4885CA1 2839/4885 |
| US-20080305497-A1 | Polymeric carriers for immunohistochemistry and in situ hybridization | FCGR2A, CD68, CA14 | CA12 8/4885CA9 76/4885CA1 37/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.